Introduction
Hodgkin's disease is a group of lymphomas characterised by malignant Reed-Sternberg and Hodgkin cells in a reactive background of lymphocytes, plasma cells, histiocytes and eosinophils (Kadin, 1994) . The nodular lymphocyte predominance subtype of Hodgkin's disease is now recognised to be a distinct clinicopathological entity, a form of B cell lymphoma (Mason et al., 1994) . The origin of the malignant cell in the other histological subtypes of Hodgkin's disease remains obscure, although recent evidence has tended to favour a lymphoid origin, with both B and T cell types (Stein and Hummel, 1993) .
Reed-Sternberg and Hodgkin cells characteristically express CD30, which is also found on activated B and T cells, and a range of other cytokine receptors such as the interleukin-2 receptors p55 (CD25) and p75, CD71 and the interleukin-6 receptor. They produce a large number of cytokines including interleukin-1a (IL-1), tumour necrosis factor (TNFa) and lymphotoxin-a (LTa) which are associated with the constitutional or B' symptoms of Hodgkin's disease ± fever, night sweats, itching and weight loss (Gorschluter et al., 1995; Gruss et al., 1997) .
Several authors have reported the presence of CD40 on Hodgkin and Reed-Sternberg cells (Carbone et al., 1995a; Gruss et al., 1994; O'Grady et al., 1994) . The number of cases expressing CD40 varied between 70% and 100% in the dierent studies, with much of this variation attributable to dierences in ®xation and the use of dierent monoclonal antibodies to CD40. A variety of functional eects have been demonstrated in the Hodgkin cell lines in response to stimulation with soluble trimeric CD40-ligand (Carbone et al., 1995a; Gruss et al., 1994 Gruss et al., , 1995 , suggesting that the CD40 on the cell surface is competent to transduce signals following interaction with its ligand.
A typical response to engagement of the IL-1, TNFa, LTa, CD30 and CD40 receptors by their cognate ligands is activation of the transcription factor NF-kB. A common feature of Reed-Sternberg and Hodgkin cells is that they have high levels of constitutively active NF-kB (Bargou et al., 1996; Gruss et al., 1997) . The NF-kB family of transcription factors plays a crucial role in the activation of many genes, the products of which have important roles in cell proliferation, the immune response and in¯ammation. In unstimulated cells NF-kB is held in the cytoplasm in an inactive form by IkB proteins. In most cases activation of NF-kB involves signal induced degradation of IkBa, thus releasing the transcription factor which translocates to the nucleus (Baeuerle and Baltimore, 1996; Baldwin, 1996; Matthews and Hay, 1995; Roulston et al., 1995) . The IkB family of proteins (a, b, g, are characterised by the presence of multiple ankyrin repeats and their ability to physically associate with NF-kB proteins (Baeuerle and Baltimore, 1996; Baldwin, 1996; Matthews and Hay, 1995; Roulston et al., 1995) . Signal induced activation of NF-kB is preceded by phosphorylation and rapid degradation of IkBa (Beg and Baldwin, 1993; Brown et al., 1993; Henkel et al., 1993; Mellits et al., 1993) mediated by the ubiquitin proteasome pathway (Palombella et al., 1994) . The target residues for signal induced modi®cation are located in the exposed N-terminus of the IkBa protein (Jaray et al., 1995) with S32 and S36 being the sites of phosphoryla-tion Brown et al., 1995; DiDonato et al., 1996; Ro et al., 1996; Traenckner et al., 1995) and K21 and K22 being the principal sites of ubiquitination (Baldi et al., 1996; Chen et al., 1995; Rodriguez et al., 1996; Scherer et al., 1995) . Signal induced modi®cation of the IkBa N-terminus, although necessary, is not sucient to promote degradation of the protein. Additional signals located within the Cterminus of the protein are also required (Brown et al., 1995; Rodriguez et al., 1995; Sun et al., 1996; Whiteside et al., 1995) . One of the results of NF-kB activation is induction of the IkBa gene and consequent resynthesis of the IkBa protein (Chiao et al., 1994; LeBail et al., 1993; Sun et al., 1993) . Resynthesized IkBa accumulates transiently in the nucleus where it is responsible for post-induction repression of NF-kB dependent gene expression and nuclear export of the transcription factor (Arenzana-Seisdedos et al., 1997).
The objective of this work was to investigate the mechanism which leads to NF-kB activation in Hodgkin cells. In all three cell lines examined the nuclear NF-kB was shown to be transcriptionally active with both p50 and p65 subunits present. Analysis of IkBa protein levels indicated that in KM-H2 cells IkBa could not be detected under normal circumstances, but a short fragment of the protein accumulated when inhibitors of proteasomal degradation were present. In L428 cells a C-terminally truncated version of IkBa was detected which was unable to associate with NF-kB and which failed to undergo signal induced degradation. HDLM-2 cells produced a more slowly migrating form of IkBa which could associate with NF-kB, but increasing the levels of this protein failed to inhibit NF-kB DNA binding activity. In each cell line the NF-kB could be inhibited by recombinant IkBa in vitro and by IkBa expressed from a transfected plasmid in vivo. Thus constitutive activation of NF-kB in Hodgkin cells appears to be a direct consequence of defective IkBa expression, even although IkBa mRNA levels appear to be normal.
Results
Hodgkin cell lines fail to activate NF-kB dependent transcription in response to CD40 ligand As engagement of CD40 by the CD40 ligand (CD40L) has been reported to activate the transcription factor NF-kB and CD40 is present on the surface of many Hodgkin cell lines (Carbone et al., 1995a) it was of interest to determine if the signal transduction pathway from CD40 to NF-kB was functional in these cells. Three well characterized Hodgkin cell lines (L428, KM-H2 and HDLM-2) and the Daudi B-cell line were transfected with either a kB dependent luciferase reporter plasmid or a similar luciferase reporter lacking NF-kB binding sites. Twenty-four hours after transfection the cells were exposed to either soluble CD40L, control supernatant or phorbol ester myristate acetate (PMA) and the reporter activity determined. Although the Daudi cells display a high level of constitutive NF-kB dependent transcription, they also show a substantial increase in kB dependent transcription following CD40L stimulation. Hodgkin cells also display constitutive NF-kB dependent reporter activity but in contrast to the Daudi cells they fail to respond substantially to CD40L (Figure 1 ). All cells do respond weakly to PMA (Figure 1 ).
High levels of NF-kB DNA binding activity in the nuclei of Hodgkin cell lines Nuclear extracts prepared following stimulation of Hodgkin cell lines and Daudi cells with CD40L were analysed for NF-kB DNA binding activity. The three Hodgkin cell lines display a high level of constitutive NF-kB DNA binding activity which is not increased in response to CD40L. Although the Daudi cells also have constitutively active NF-kB DNA binding activity it is less than that observed in the Hodgkin cells and it is increased substantially in response to CD40L ( Figure  2) . Analysis of the NF-kB DNA complex by supershifting with antibodies to Rel family members reveals that heterodimers of p50 and p65 are present in all cases. While supershifting with the p65 antibody was incomplete no supershifts were detected with antibodies to p52, c-rel and rel B although there were indications that DNA binding activity was reduced after addition of c-rel antibody. DNA binding activity was abolished by incubation with recombinant IkBa (Figure 2 ). It is therefore likely that the constitutive DNA binding activity present in the nuclei of Hodgkin cell lines is composed of p50 and p65 heterodimers which are not abnormal in their ability to be inhibited by IkBa.
Defective IkBa in Hodgkin cell lines
In cells of the haematopoietic lineage NF-kB activity is regulated by IkBa (Beg et al., 1995; Haskill et al., 1991) . The metabolism of IkBa was therefore examined in Hodgkin cells and Daudi cells after treatment with CD40L. Western blot analysis with a monoclonal antibody directed against the N-terminus of IkBa Figure 1 Hodgkin cell lines fail to activate NF-kB dependent transcription in response to CD40 ligand. 3enhconAluc or conAluc luciferase reporter plasmids were transfected into the indicated cell lines by the DEAE dextran procedure. Twenty-four hours after transfection cells were exposed to either CD40 ligand (CD40L), a control supernatant or PMA. Six hours later cells were harvested and luciferase activity determined in a luminometer. Activity is expressed as relative light units (r.l.u.) per mg of protein revealed apparently normal IkBa of 38 kD in Daudi cells (Figure 3) . In L428 cells the 38 kD form of IkBa was not detected, but was replaced by a faster migrating species of 30 kD ( Figure 3 ). HDLM-2 cells contain two species of IkBa that have a slightly slower electrophoretic mobility than the form apparent in Daudi cells. IkBa was not detected in KM-H2 cells ( Figure 3 ). Identical results were obtained when a polyclonal antibody raised against recombinant IkBa (Mellits et al., 1993) was used in Western blot analysis 0  0  30  30  60  60  120  120  0  0  30  30  60  60  120  120  0  0  30  30  60  60  120  120  0  0  30  30  60  60  120 120
Figure 2 NF-kB DNA binding activity in the nuclei of Hodgkin cells. Cell lines were exposed to either control supernatant (7) or supernatant from cells expressing CD40 ligand (+) for the indicated period of time prior to nuclear extract preparation. NF-kB DNA binding activity in 5 mg of nuclear extract was determined in a gel electrophoresis DNA binding assay using a (7) or supernatant from cells expressing CD40 ligand (+) for the indicated periods of time prior to preparation of cytoplasmic extracts. 25 mg of cytoplasmic extract was analysed by Western blotting using the 10B monoclonal antibody speci®c for IkBa (upper panels). Antibodies were stripped from the blots, which were then exposed to peptide antibodies speci®c for IkBb (lower panels). The positions of prestained molecular weight markers are indicated (data not shown). While stimulation with CD40L produces the characteristic loss and resynthesis of IkBa in Daudi cells, this is not the case for the IkBa species in HDLM-2 and L428 cells ( Figure 3 ). After CD40L stimulation of HDLM-2 cells the faster migrating species of IkBa disappears, but there is little change in the level of the more slowly migrating form of IkBa. Stripping and reprobing these membranes with the polyclonal antibody to IkBb shows that all three Hodgkin cell lines and the Daudi cells contain the IkBb protein.
The level of IkBb does not change over the 2 h period of stimulation with CD40L ( Figure 3 ).
Agents which allow IkBa to accumulate do not in¯uence NF-kB activity in Hodgkin cell lines
Dexamethasone treatment of cells has been reported to increase IkBa levels as a consequence of increasing the level of IkBa mRNA (Auphan et al., 1995; Scheinman et al., 1995) . IkBa levels can also be increased by inhibiting proteasome mediated degradation with the peptide aldehyde inhibitor ZLLLH (Ro et al., 1996) . Daudi and Hodgkin cell lines were therefore exposed to either dexamethasone, ZLLLH or a combination of both and NF-kB DNA binding activity was determined in a gel electrophoresis DNA binding assay ( Figure  4a ). IkBa levels were determined by Western blotting (Figure 4b ). In Daudi cells treatment with ZLLLH either in the absence or presence of dexamethasone results in a small decrease (30 ± 40%) in NF-kB DNA binding activity ( Figure 4a ) and a corresponding increase in the levels of IkBa (Figure 4b (Figure 4b ). HDLM-2 cells show a striking shift to more slowly migrating forms of IkBa when the cells are treated with ZLLLH. Although dexamethasone alone has only a minor eect on IkBa levels, the combination treatment results in a signi®cant increase in the total amount of IkBa protein ( Figure  4b ). An identical result was obtained when the blots were probed with a previously described (Mellits et al., 1993) polyclonal antiserum raised against recombinant IkBa (data not shown). Stripping and reprobing the blot with an antibody to IkBb indicated that over the time scale of the experiment levels of this protein were not aected by treatment with dexamethasone or ZLLLH (data not shown). It is therefore clear that in L428 and HDLM-2 cells increasing the level of IkBa protein does not bring about a corresponding decrease in NF-kB DNA binding activity. In an attempt to detect fragments of IkBa that may result from rapid degradation of the protein, KM-H2 cells were treated with either the protease inhibitor TPCK, the fungal gliotoxin or the proteasome inhibitor ZLLLH and proteins separated on a high concentration polyacrylamide gel. Western blot analysis of the transferred protein with IkBa antibodies revealed the presence of a small fragment of IkBa that was detected after treatment with ZLLLH, but not TPCK or gliotoxin (Figure 4c ). This fragment is derived from the Nterminus of the protein as the monoclonal antibody used for detection recognises an epitope located in the N-terminus of IkBa (Jaray et al., 1995) .
Association of IkBa with NF-kB in Hodgkin cell lines
To determine if the truncated IkBa observed in L428 cells and the more slowly migrating form of IkBa in HDLM-2 cells could associate with NF-kB, proteins were immunoprecipitated from cell extracts with (Figure 5a ). As IkBa could not be detected in KM-H2 cells (Figures 3 and 4) this was expected but it demonstrates that the truncated version of IkBa observed in L428 cells is unable to associate with NF-kB. The protein present in L428 was readily immunoprecipitated with polyclonal antisera to recombinant IkBa and the 10B monoclonal antibody but not with antibodies to p50 or p65 (Figure 5b ). The form of IkBa present in L428 cells is likely to be truncated at the C-terminus as the 10B monoclonal antibody recognizes the N-terminus of the protein. This was con®rmed when the blot was stripped and reprobed with an antibody directed against the extreme Cterminus of IkBa. This antibody recognised the proteins present in Daudi and HDLM-2 cells but did not react with the truncated IkBa in L428 cells ( Figure  5c ).
IkBa mRNA in Hodgkin cells
As IkBa protein was not detected in KM-H2 cells and a truncated form of the protein was present in L428 cells, RNA analysis was performed. Total RNA from Jurkat T-cells and the Hodgkin cells was analysed by Northern blotting using an IkBa cDNA as probe. It is clear that all of the Hodgkin cell lines have greater than normal levels of IkBa mRNA that, within the resolving power of the gel, appears to be full length ( Figure 6 ).
Introduction of IkBa into Hodgkin's cell inhibits endogenous NF-kB activity
The high level of nuclear NF-kB in the Hodgkin cells and the presence of apparently defective forms of IkBa suggested that transfer of the wild type IkBa gene into these cells could inhibit NF-kB activity. A potential explanation for the defective IkBa in these cells is that the signal transduction pathway which results in IkBa Cytoplasmic extracts from the indicated cell lines were immunoprecipitated with either preimmune serum (7), antibodies to p50 or antibodies to p65. Immunoprecipitates were analysed by Western blotting using the 10B monoclonal antibody speci®c for IkBa (a). Cell extracts from the indicated cell lines were analysed by Western blotting using the 10B monoclonal antibody, which recognises an epitope in the N-terminus of IkBa (b) or antibodies directed against the C-terminus of IkBa (c).
Prior to Western blotting extracts from L428 cells were immunoprecipitated with either preimmune serum (7) degradation has been activated. To test this possibility an IkBa S32A, S36A mutant, which fails to undergo signal induced degradation (Ro et al., 1996) was also tested. KM-H2 cells were electroporated with an NFkB dependent luciferase reporter (HIV LTR luc) along with plasmids expressing wild type IkBa, IkBa S32A, S36A or empty vector (pcDNA). An equivalent reporter in which the kB motifs were mutated (DkB HIV LTR luc) was used as control. The high level of kB dependent reporter activities in the KM-H2, L428 and HDLM-2 cells is reduced by introduction of either wt IkBa or IkBa S32A, S36A into these cells, although the extent of inhibition by the ectopic IkBa species varies between cell lines (Figure 7) . Inhibition of NFkB dependent reporter activity by ectopic wild type ImBa is less pronounced in HDLM-2 cells, but reporter activity is reduced to basal levels by the S32A, S36A mutant of IkBa. Levels of expressed IkBa were determined by Western blotting of the electroporated cells. No substantial dierences in the accumulated levels of IkBa or IkBa S32A, S36A were detected (Figure 7 , insert), suggesting that the lack of IkBa in the KM-H2 cell is not due to permanent activation of the normal signal transduction pathway that leads to IkBa degradation.
Discussion
The conclusion of this study is that constitutive activation of NF-kB observed in Hodgkin cell lines (Bargou et al., 1996; Gruss et al., 1997 ; this study) is a consequence of defective IkBa. In KM-H2 cells IkBa cannot be detected under normal circumstances, but an 18 kD fragment of IkBa is detected after treatment of the cells with an inhibitor of proteasomal degradation ( Figure 5 ). We were unable to detect any full length IkBa with a range of polyclonal and monoclonal antibodies. These data indicate that in KM-H2 cells an unstable 18 kD fragment of IkBa is made which is rapidly degraded by the proteasome. It is unlikely that an unusual, proteasome independent, processing event is taking place as wild type IkBa introduced into these cells appears at the expected molecular weight ( Figure  7) . A similar situation is apparent in L428 cells in which a truncated version of IkBa is also detected. In this case the truncated protein has a molecular weight of about 30 kD and so should contain about 250 of the 317 amino acids in IkBa. The short proteins from KM-H2 and L428 cells both appear to be truncated at the C-terminus as they are detected by the 10B monoclonal antibody which recognises an epitope located between K21 and E48 in IkBa (Jaray et al., 1995) , but are not detected by an antibody raised against the C-terminal 12 amino acids of IkBa. Consistent with previous deletion and partial proteolysis experiments Hatada et al., 1993; Jaray et al., 1995; Rodriguez et al., 1995) the truncated form observed in L428 cells is unable to interact with NF-kB and would thus be incapable of retaining NF-kB in the cytoplasm or inhibiting NF-kB DNA binding activity. Treatment of L428 cells with the proteasome inhibitor ZLLLH leads to signi®cant accumulation of the truncated IkBa protein ( Figure 5 ) suggesting that, as in KM-H2 cells, the truncated forms of IkBa which fail to bind NF-kB are being rapidly turned over. This would be expected as it is known that free and NF-kB bound IkBa have a dierent susceptibility to proteolytic degradation (Sun et al., 1993) . The situation in HDLM-2 cells is somewhat dierent as they contain constitutively active NF-kB even although full length IkBa, which can associate with NF-kB, is detected. However, this protein appears to have a slightly slower electrophoretic mobility, in polyacrylamide gels containing SDS, than IkBa from Daudi cells (Figure 3 ± 5) . Treatment of these cells with a combination of ZLLLH and pcDNA IκBα IκBα S32A, S36A Figure 7 Introduction of IkBa in Hodgkin cells inhibits constitutive NF-kB activity. An NF-kB dependent luciferase reporter (HIV LTR luc) and a control plasmid lacking functional NF-kB binding sites (DkB HIV LTR luc) were co-electroporated into KM-H2 (a), L428 (b) and HDLM-2 (c) cells with expression plasmids for either IkBa, S32A S36A IkBa or empty vector pCDNA3. Twentyfour hours after electroporation cell extracts were prepared for determination of luciferase activity (R.L.U. in 100 mg protein) and expression of IkBa in KM-H2 cells was determined by Western blotting (10 mg protein) with the 10B monoclonal antibody dexamethasone results in the accumulation of substantial quantities of what appears to be phosphorylated IkBa (Figure 5 ), again suggesting that IkBa is being rapidly turned over. Although IkBa accumulates under the above conditions it does not reduce the NFkB DNA binding activity present in the cell nucleus, thus suggesting that the IkBa present in HDLM-2 cells is functionally defective. An alternative explanation for these ®ndings is that the nuclear NF-kB is refractile to inhibition by IkBa as would be expected if the nuclear NF-kB was being shielded bound to IkBb . This is unlikely as the nuclear DNA binding activity is eciently inhibited by recombinant IkBa in vitro (Figure 2 ) and NF-kB dependent transcription is inhibited after electroporation of a plasmid expressing IkBa (Figure 7 ). There are interesting parallels between this work on Hodgkin cell lines and observations made on IkBà knockout' mice (Beg et al., 1995) . The IkBa de®cient mice die within a few days of birth and show high levels of constitutive NF-kB activation, particularly in haematopoietic cells. As in the Hodgkin cell lines, the mice also show increased transcription of some, but not all, NF-kB responsive genes (such as G-CSF).
The extent to which the neoplastic phenotype of Hodgkin cells is dependent on their defective IkBa and deregulated NF-kB remains to be established. In a previously published study on Hodgkin cells all cells contained constitutively active NF-kB and while IkBa was not analysed in L428 cells, Western blotting of extracts from KM-H2 and HDLM-2 cells indicated that immunoreactive material which comigrated with wild type IkBa was detected at a very low level (Bargou et al., 1996) . Although not mentioned, these authors also detected a more slowly migrating form of IkBa which could correspond to that observed in this report. A reason for the apparently contradictory results observed in KM-H2 cells is not clear, but dierent antibodies to IkBa were employed. The IkBa speci®c monoclonal antibody used in this study is very sensitive allowing excellent discrimination between the signal for IkBa and non-speci®c signals. Deregulated expression of NF-kB in the neoplastic Hodgkin and Reed-Sternberg cells could account for the characteristic phenotype of these cells with expression of activation markers and production of cytokines. Involvement of NF-kB in cell proliferation is suggested by activation of NF-kB during the cell cycle , by virtue of a p300 mediated interaction between p65 and cyclin E-Cdk3 (Perkins et al., 1997) . A further important role of constitutively active NF-kB in the Hodgkin cells may be to prevent apoptosis. It has been demonstrated that NF-kB activation is required to protect cells from TNF mediated apoptosis (Beg and Baltimore, 1996; van Antwerp et al., 1996; Wang et al., 1996) , while in Bcells TGFb promotes apoptosis by inducing synthesis of IkBa which blocks the activity of NF-kB (Arsura et al., 1996) . The role played by constitutively active NF-kB in B cells appears to be in transcription of the c-myc proto-oncogene, the promoter of which is responsive to NF-kB (Duyao et al., 1990) . Direct evidence for the oncogenic potential of NF-kB is provided by the known variants of Rel family members which are associated with tumours. v-Rel is a mutated form of c-Rel isolated from the acutely transforming REV-T retrovirus. It is a potent oncogene in avian cells and infection of young chickens with the REV-T retrovirus causes multiple haematopoietic tumours of the spleen and liver, typically resulting in death after 7 ± 10 days (Bose, 1992; Gilmore, 1991) .
The human IkBa gene on chromsome 14 (Glavac et al., 1994) does not appear to be commonly associated with chromosome breaks or deletions in cases of Hodgkin's disease (Koduru et al., 1993) . Although this is consistent with our data indicating the IkBa mRNA is of apparently normal electrophoretic mobility on a Northern blot (Figure 6 ) cytogenetic studies are dicult to perform in these tumours and the results do not exclude the possibility of smaller scale alterations in the IkBa gene.
The results presented here suggest that loss of functional IkBa in Hodgkin cell lines could account for the characteristic activated phenotype of these cells, their deregulated cytokine secretion and consequently the clinical and pathological manifestations of Hodgkin's disease.
Materials and methods

Cell lines
Three well-characterised Hodgkin cell lines were used for these experiments. The HDLM-2 and KM-H2 lines were obtained from the DSM cell line collection and the L428 cell line was provided by Professor Harald Stein. All three cell lines were independently derived from patients with disseminated Hodgkin's disease. The KM-H2 line originated from a patient with mixed cellularity Hodgkin's disease, and the other lines from patients with nodular sclerosing Hodgkin's disease. The HDLM-2 cell line was cultured in RPMI supplemented with 20% heat inactivated foetal calf serum. The other cell lines were grown in RPMI 1640 with 10% foetal calf serum.
Antibodies
The Mad 10B monoclonal antibody was generated against recombinant full-length IkBa and recognises an epitope in the N-terminus (Jaray et al., 1995) . Rabbit antibodies against the IkBa C terminus (residues 297 ± 317), IkBb C terminus (residues 339 ± 358), and p65/RelA (residues 531 ± 550) were obtained from Santa Cruz Biotechnology, Inc. Polyclonal rabbit antisera to recombinant p50, p65 and IkBa were as described . Rabbit antibodies to p49 were generated by immunisation with bacterially produced recombinant protein.
Cell stimulations and preparation of extracts
Cells were collected by centrifugation and resuspended in 8 ml of medium at a concentration of 3610 6 cells/ml. 24-well Costar plates were prepared with stimulating reagents at the appropriate concentration.
CD40-ligand CHO supernatant and CHO control supernatant were obtained from Immunex, Seattle and were used at a dilution of 1/250. The proteasome inhibitor ZLLLH was synthesised as described (Ro et al., 1996) and used at 10 mM. Dexamethasone (Sigma) was used at a concentration of 1 mM.
Cell suspensions were added to the plate at 1 ml/well and cells which were not removed immediately for lysis were incubated at 378C. At each time point, cells from a single well were washed in ice-cold PBS and lysed in 300 ml buer containing 20 mM sodium phosphate pH 7.5, 50 mM sodium ¯uoride, 5 mM tetra sodium pyrophosphate, 10 mM bglycerophosphate, 0.5% NP-40 and protease inhibitors (1 mM leupeptin, 1 mM pepstatin, 1 mM pefablock and 20 mM TPCK). After centrifugation to collect nuclei, the cytoplasmic fraction was removed and the nuclei washed twice in lysis buer before resuspension in lysis buer containing 425 mM NaCl. After 30 min on ice, the extracts were clari®ed by centrifugation at 13 000 r.p.m. for 20 min at 48C in an Eppendorf microfuge. Extracts were used immediately or stored at 7708C.
Western blotting
Cytoplasmic extracts containing 25 mg protein (Bradford, 1976) were resolved in a 10% polyacrylamide gel containing SDS, and transferred to Immobilon PVDF membranes (Millipore) by semi-dry electroblotting. Membranes were incubated in blocking buer (TBS containing 5% skimmed milk and 0.1% Tween 20) for 1 h, followed by primary antibody diluted in the same buer. Monoclonal antibody Mad 10B hybridoma supernatant was diluted 1/100 and commercial polyclonal antibodies to IkBb or the Cterminus of IkBa (Santa Cruz Biotechnology, Inc.) were used at a concentration of 2 mg/ml. Membranes were washed in TBS containing 0.1% Tween 20. Speci®cally-bound antibody was detected using peroxidase-conjugated goat anti-mouse (DAKO, 1/750) or goat anti-rabbit (DAKO, 1/500) and the Amersham ECL system.
When indicated, membranes were stripped by incubation in 60 mM Tris HCl pH 6.8, 2% SDS and 100 mM bmercaptoethanol at 708C for 30 min. After extensive washing in TBS-Tween, membranes were blocked again and probed with antibody as before.
Gel electrophoresis DNA binding assays NF-kB binding assays were performed as described (Arenzana-Seisdedos et al., 1995) with 5 mg nuclear protein and a 32 P-labelled double stranded DNA oligonucleotide representing the upstream kB motif present in the HIV-1 enhancer. Free DNA was resolved from the DNAprotein complexes on a native 6% polyacrylamide gel and the positions of radioactive species determined by phosphorimaging of the dried gel. The subunit composition of DNA-protein complexes containing NF-kB was determined by pre-incubation of nuclear extracts with polyclonal antibodies to p50, RelA/p65, c-Rel, p49 or RelB. Additional samples were pre-incubated with 10 ng recombinant IkBa (Jaray et al., 1995) .
NF-kB dependent reporter assays
NF-kB dependent luciferase reporters were HIVLTRluc and 3EnhConAluc, while control reporters lacking functional NF-kB binding sites were DkBHIVLTRluc and ConAluc (Alcami et al., 1995; Rodriguez et al., 1996) .
Expression plasmids for IkBa and S32A, S36A IkBa have been described previously (Ro et al., 1996) . Plasmids were introduced into cells either by DEAE dextran mediated transfection (Pazzagli et al., 1992) or electroporation (Alcami et al., 1995) . Where indicated cell stimulations were carried out 24 h after transfection for a period of 6 h with either CD40 ligand supernatant (diluted 1 in 250), control supernatant or 100 ng/ml phorbol myristate acetate (PMA). Cells were collected by centrifugation and the luciferase activity in cell lysates determined as described previously .
Northern blotting
RNA was isolated by acid guanidinium thiocyanate phenol chloroform extraction (Chomczynski, 1992) , fractionated in agarose gels containing formaldehyde and transferred to nylon membranes as described (Chomczynski and Sacchi, 1987) . The RNA was hybridised to 32 P-labelled DNA representing the coding region of the human IkBa gene prepared by random priming (Pharmacia). Radioactive species were detected by phosphorimaging.
Immunoprecipitations
Cells (2610 7 ) were collected by centrifugation, washed in PBS and lysed in 1 ml of buer containing 50 mM Tris. HCl pH 7.4, 150 mM sodium chloride, 0.5% Nonidet-P40, 1 mM sodium orthovanadate and protease inhibitors as above. Following centrifugation at 6000 r.p.m. for 3 min in an Eppendorf microfuge, the supernatant was pre-cleared three times with 100 ml of Protein G-Sepharose (Pharmacia). Tubes containing 25 ml Protein G (Pharmacia) were pre-loaded with: 200 ml PBS, 2 mg polyclonal antip65 (Santa Cruz Biotechnology, Inc.), 1 ml anti-p50 rabbit serum, 1 ml anti-IkBa rabbit serum, or 200 ml anti-IkBa (Mad 10B) tissue culture supernatant. All volumes were made up to 200 ml with PBS and the tubes allowed to rotate for 1 h at 48C. Pre-loaded Protein G was washed twice with lysis buer and the pre-cleared lysate divided between the antibody tubes. These were then allowed to tumble again for 1 h at 48C. Immunoprecipitates were washed three times in lysis buer, boiled in reducing sample buer diluted 1:1 in distilled water and analysed by SDS ± PAGE and Western blotting.
